SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NPSP NPS Pharmaceutical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
363 40 0 NPSP
Emcee:  Jim Langdon Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
338[graphic] New Steps 2 data includes patient deaths. Butuck-10/31/2011
337>>BEDMINSTER, N.J.--(BUSINESS WIRE)-- NPS Pharmaceuticals, Inc. (NASDAQ: Ntuck-8/15/2011
336And still expecting to file by EOY for SBS: >>BEDMINSTER, N.J.--(BUSINESStuck-8/2/2011
335New calcilytic agreement with GSK: >>BEDMINSTER, N.J.--(BUSINESS WIRE)-- tuck-8/2/2011
334Nycomed files for EU approval of GATTEX, reportedly triggering a "mid seventuck-3/28/2011
333February 15, 2011, 4:30 pm BEDMINSTER, N.J.--(BUSINESS WIRE)-- NPS Pharmaceuticatuck-2/15/2011
332Can't say it has paid off, but it's not nearly as underwater as it was atuck-1/31/2011
331great to finally see that investment payoff, it certainly has been a long and tomopgcw-1/31/2011
330With today's news of GATTEX meeting primary endpoints, the stock has hit a mtuck-1/31/2011
329We are now looking at early 2012 for Gattex launch, with money sufficient only ttuck-4/14/2010
328And the calcilytic whiffs: >>NPS Pharma says Glaxo stops osteoporosis drutuck-9/26/2008
327>>NPS Reports Successful GATTEX(TM) Extension Study Monday March 17, 4:00 tuck-3/17/2008
326>>Nycomed has decided to continue development of GATTEX, which is a big retuck-1/28/2008
325Nycomed has decided to continue development of GATTEX, which is a big relief to tuck-10/31/2007
324>>Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Shorttuck-10/11/2007
323>>NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Mtuck-10/9/2007
322MSTAR: We're placing NPS Pharmaceuticals NPSP under review as we digest a nmopgcw-9/28/2007
321Tuck; Might have leaked early! Interesting discussion on Yahoo wondering why tSteve Lokness-9/27/2007
320>>NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(tuck-9/26/2007
319>>NPS Pharmaceuticals Announces Sale of Preotact(R) Royalty to Drug Royalttuck-7/16/2007
318>>NPS Pharmaceuticals Expands Agreement with European Partner Nycomed to Ituck-7/9/2007
317>>NPS Announces Progression of the Calcilytics Development Program in Ostetuck-6/4/2007
316mstar: We're placing NPS Pharmaceuticals NPSP under review while we evaluatmopgcw-3/15/2007
315Citi: NPSP: Few Catalysts Near-Term; Maintain Hold & Revising Tgt Price HOmopgcw-8/11/2006
314Signals on the osteoporosis space: signalsmag.com Didn't tell me much new,tuck-8/8/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News